Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients

Part of paid clinical trials in Providence, Rhode Island.

Sponsor
Brown University
Study ID
NCT04201288
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Acceptance-Based Behavior Therapy (ABBT) — BEHAVIORAL
    Acceptance-Based Behavior Therapy (ABBT) In the first session, the interventionist will introduce the concept of acceptance and its possible benefits in the context of life values and participant-identified barriers to retention in care. Interventionists will help participants identify potential challenges to acceptance, including disclosure concerns. At the second session, participants will practice acceptance-based coping skills and a behavioral plan will be developed to target barriers identified in the first session. These discussions will help the participant clarify how best to align their values with decisions on how to manage their HIV.
  • Enhanced-Treatment-as-Usual (ETAU) — BEHAVIORAL
    ETAU will consist of two brief sessions lead by study interventionists, performed at the same times and by same methods as ABBT. Topics of education include safe sex practices, review of treatment options, and review of HIV-related indices of health.

Study Details

The overall aim of this program of research is to test a newly developed intervention, Acceptance-Based Behavior Therapy (ABBT), to improve HIV patients' commitment to medical care. The purpose of the proposed project is to establish the efficacy of ABBT and examine its mechanisms of action. To achieve the specific aims, the investigators will conduct a randomized clinical trial (n = 270), with two treatment arms: ABBT vs. an attention-matched HIV education control condition.

Key Dates

Start date
Dec 21, 2020
Status verified
Sep 2025
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025

Study Design

Enrollment
38 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Acceptance-Based Behavior Therapy (ABBT)
    The 2-session ABBT will be delivered in person at session 1 and by telephone at session 2.
  • Placebo Comparator: Enhanced-Treatment-as-Usual (ETAU)
    In addition to receiving treatment-as-usual at the clinic, ETAU participants will receive a 2-session program of HIV education.

Primary Outcome Measure

Number of Participants Meeting Retention in HIV Medical Care Guidelines at 52 Weeks [ Time Frame: 52 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Brown UniversityProvidenceRhode Island02912-

Find similar trials in Providence, RI

By condition
HIV
By specialty
Infectious disease
By research site
Brown University· Providence, RI

Related Studies